Strategic Minerals Stock
Strategic Minerals Stock
Strategic Minerals took a tumble today and lost -€0.001 (-6.900%).
Pros and Cons of Strategic Minerals in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Strategic Minerals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Strategic Minerals | -6.900% | 11.538% | 45.000% | 1350.000% | 16.000% | 2800.000% | 504.167% |
| Bodycote plc | 0.600% | 4.348% | 9.804% | 7.006% | 6.329% | 12.752% | -1.176% |
| Hanwa Co Ltd | -0.500% | 3.608% | 4.145% | 39.583% | 5.236% | 57.031% | 77.876% |
| Daido Steel | - | 16.763% | 18.129% | 43.262% | 17.442% | -67.419% | -71.629% |
News
Coastal Financial Insider Sells Another $1.3 Million in Stock as Shares Rise 47%
Coastal Financial Corporation (NASDAQ:CCB) CEO Eric Sprink executed open-market sales totaling 11,000 shares for approximately $1.28 million on Tuesday and Wednesday, according to a recent SEC Form
This ETF Is Up 146% as the Battle Over Rare Earths Heats Up
The materials sector doesn't get a lot of love. After finishing last among all 11 S&P 500 sectors in 2024, it mustered a 10% gain last year, which trailed the broad market.
But as with any
Ironwood Pharmaceuticals’ 2026 Guidance Shock Sparks a Major Re-Rating
The pharmaceutical sector is famously volatile, usually driven by the binary outcomes of clinical trials. A drug either works, sending the stock to the moon, or it fails, causing a crash